The Historical Evolution of Ocular Tuberculosis: Past, Present, and Future

Ocul Immunol Inflamm. 2022 Apr 3;30(3):593-599. doi: 10.1080/09273948.2021.1992446. Epub 2021 Nov 9.

Abstract

Ocular involvement is a rare manifestation of tuberculosis. Four key issues historically faced by clinicians when diagnosing and treating ocular tuberculosis - diagnostic uncertainty, naturally heterogeneous presentations, limitations of existing laboratory diagnostic tools, and non-uniform treatment guidelines - continue to test today's physicians. Unparalleled scientific and clinical developments over the past century have greatly expanded the knowledge surrounding this challenging ophthalmic condition. Experience with large volumes of cases at tuberculosis-endemic centres has led to recent growth in knowledge and physician experience, perhaps more so in developing countries. Looking forward, the role of diverse new technologies, including artificial intelligence and proteomics, will advance ocular tuberculosis research. Efforts have been made to address the lack of standardized nomenclature, diagnostic uncertainty, and unvalidated, geographically variable treatment guidelines.

Keywords: History; artificial intelligence; consumption; inflammation; ocular tuberculosis; proteomics; tuberculosis; uveitis.

Publication types

  • Case Reports

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Artificial Intelligence
  • Eye
  • Humans
  • Tuberculosis* / diagnosis
  • Tuberculosis, Ocular* / diagnosis
  • Tuberculosis, Ocular* / drug therapy

Substances

  • Antitubercular Agents